Recent findings regarding hidradenitis suppurativa (HS) highlight a possible genetic link to Alzheimer’s disease, said Ginette A. Hinds, M.D., at the 2012 American Academy of Dermatology Summer Academy Meeting.
Research continues to elucidate how the human papillomavirus (HPV) contributes to the development of skin cancer, particularly squamous cell carcinoma (SCC), said Eggert Stockfleth, M.D., at MauiDerm 2012: Advances in Cosmetic and Medical Dermatology.
The safety and versatility of photodynamic therapy (PDT) make it a worthwhile addition for dermatologists not yet providing this treatment, according to Amy Forman Taub, M.D., who spoke at the 2011 annual meeting of the American Society of Cosmetic Dermatology and Aesthetic Surgery.
Aside from hypercalcemia, risks of acute or chronic vitamin D doses above the level deemed safe by the Institute of Medicine are perhaps real, but they’re difficult to measure at present, says Christopher Burnett, M.D.
In the quest for new vaccines, developers must balance clinical promise with practical concerns, said Kenneth Tomecki, M.D., at the 70th annual meeting of the American Academy of Dermatology. "The future for vaccines is very encouraging," says Dr. Tomecki, vice chairman, department of dermatology, Cleveland Clinic.
Social media allow for efficient networking with patients and colleagues, but using these tools successfully with patients requires setting limits and delegating authority.
Achieving meaningful use and avoiding common mistakes in implementing an electronic health record (EHR) system require careful planning and learning from others' experiences, said Michael Doyle, chairman of Medsphere Systems Corporation, at the 70th annual meeting of the American Academy of Dermatology.
A systematic approach helps to guide the workup and management of female pattern alopecia (FPA), according to Mary Gail Mercurio, M.D.
Although sentinel lymph node biopsy (SLNB) may be useful for staging of intermediate-thickness melanomas, says Pamela Basuk, M.D., its utility elsewhere is questionable.
Newer drugs are available to combat potentially serious infections including methicillin-resistant Staphylococcus aureus (MRSA), says Kenneth J. Tomecki, M.D., vice-chairman, department of dermatology, Cleveland Clinic. Colonization, mainly of the anterior nares, remains a major risk factor for MRSA.